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Introduction: Turner’s Syndrome (TS) is associated with hearing disorders in about 20 to 50% 
of affected individuals. The most common hearing disorders include congenital auricular mal-
formations, recurrent otitis media and sensorineural hearing loss, although altered vestibular 
function and tinnitus have also been reported. 
Objectives: The aim of this paper is to provide an up-to-date overview of the principal findings 
and research perspectives about the association between TS and hearing disorders.
Review: Middle ear disorders, found in a range between 21 and 91% of subjects, are a conse-
quence of morphological cranio-facial alterations resulting in middle ear ventilation dysfunc-
tion. Sensorineural hearing loss follows 2 main audiological profiles: a bilateral symmetrical 
mid-frequency dip and a high frequency down-sloping curve. Although the pathophysiologic 
basis of sensorineural hearing loss in TS patients are still unclear, several hypothesis have been 
made so far and are reviewed in this paper.
Conclusion: Literature confirms that hearing disorders, although not the most relevant clinical 
problem in these patients, have a high incidence in patients with TS and should therefore un-
dergo early evaluation and monitoring over time.
KEYWORDS: Turner’s Syndrome (TS); Hearing disorders; Hearing loss; Tinnitus.
ABBREVIATIONS: TS: Turner’s Syndrome; SNHL: Sensorineural hearing loss; ABR: Auditory 
Brainstem Responses. 
INTRODUCTION
Turner’s Syndrome (TS), a common chromosomal condition with an estimated incidence of 1 
per 2,000 women,1 is associated with hearing disorders in about 20 to 40% of affected individu-
als. TS, also known as 45,X, is caused by a complete or partial deletion of one of X chromo-
somes; affected subjects are characterized by short stature, typical dysmorphic features, cardiac 
abnormalities, gonadal dysgenesis, congenital lymphoedema, renal malformations, obesity, 
diabetes and other minor somatic anomalies described by the Turner’s Syndrome Association.2 
Intelligence is usually within normal range, minor problems with non-verbal, social and psy-
chomotor skills may be present.3
 The most common hearing disorders found in patients with TS include congenital 
auricular malformations, recurrent otitis media and sensorineural hearing loss.4 Current stud-
ies available in the literature report an incidence of hearing loss in about 50% of patients with 
TS: 60% for sensorineural hearing loss, 25% for conductive hearing loss, and 15% for mixed 
hearing loss.4-7 Asymptomatic vestibular dysfunction and tinnitus have also been reported, but 
only in the form of case reports; the first could be due to the impact of estrogen on the vestibule, 
while the second could be a consequence of hearing deafferentation (Table 1).8 
 Conductive hearing loss may be a consequence of lymphatic hypoplasia, common in 
TS, with lymphatic effusion in the middle ear predisposing to adhesions and impaired aeration 
and drainage, as well as of morphological alterations of the eustachian tube and middle ear 







dimension, and causing inadequate ventilation of the middle 
ear. The most common alterations include cylindrical shape of 
the tympanic ostium of the tube, hypotonia of tensor veli pala-
tini muscle and mastoid hypocellularity. This results in chronic 
ventilation dysfunction often followed by chronic otitis media 
sometimes associated to cholesteatoma.9
 Sensorineural hearing loss (SNHL) in TS represents a 
relatively recent finding and seems to be independent from mid-
dle ear diseases; several hypothesis about the pathophysiologic 
basis have been made so far, but still remain unclear. The most 
common sensorineural audiological finding in TS patients con-
sists in a bilateral symmetrical mid-frequency dip, mainly at 2 
kHz, probably correlated to karyotype.10 In some patients, high 
frequency down-sloping SNHL can also be present. SNHL in TS 
patients can have an early onset, starting during the first decade 
of life or, most commonly, during the second and third decades, 
with a tendency to worsen over time. Studies have attributed 
the mid-frequency dip to cell cycle delay that is more evident in 
the middle turn of the cochlea where hair cells have the highest 
concentration per millimeter length of the organ of Corti.11,12 The 
early onset of the high-frequency hearing loss may instead be 
a consequence of a faster apoptotic process of hair cells in the 
basal turn. Estrogen deficiency could play an important role in 
these processes through its action on estrogen receptors in the 
inner ear.10,13 It is also important to mention that different altera-
tions of auditory brainstem responses (ABR) have been reported 
in TS, revealing possibly impaired cochlear nerve function to the 
level of brainstem.
OBJECTIVES
Although several papers have been published about the associa-
tion between Turner’s Syndrome and hearing disorders, some 
aspects, especially for patients with sensorineural hearing loss, 
are still debated and certainly need more clinical and basic re-
search studies.14 The purpose of this review paper is to provide 
an up-to-date overview of the principal findings and research 
perspectives about such association.
REVIEW OF THE LITERATURE
Several studies have focused on the hearing function in patients 
with TS. From a literature research, 26 studies that focused on 
hearing disorders in patients with TS have been found (Table 2). 
Studies have been published between 1988 and 2015, with an 
average of 0.89/year (Figure 1). The most relevant are reported 
in the following paragraph.
Conductive/mixed hearing loss Frequency
Acute otitis media Common
Recurrent acute otitis media Common
Otitis media with effusion Uncommon
Cholesteatoma Rare
Retraction pocket Common
Perforation of the tympanic membrane Uncommon
Sensorineural hearing loss
Bilateral high frequencies hearing loss Common
Bilateral mid frequencies hearing loss Common
Profound hearing loss (>85 dBHL) Very Rare
Other 
Tinnitus Case Report
Asymptomatic vestibular dysfunction Case Report
Table 1: Audiological findings reported in patients with Turner’s Syndrome with re-
lated frequency.
Figure 1: Frequency of studies reporting audiological findings in patients with 







 In 2003, Hultcrantz10 performed audiometric and karyo-
type exams in 325 women with TS, finding otitis media in 61% 
and SNHL in 80% of the individuals studied, most of them hav-
ing the 45XO or 45XO/46Xi(Xq) karyotype. In 2005, Dhooge23 
published a prospective study with a questionnaire and audiolog-
ic evaluation in 41 patients with TS (median age: 24 years), find-
ing pure sensorineural hearing loss in one-third of the patients 
(38.8%) and pure conductive losses in one-fifth (21.3%). The 
remaining 60.1% had normal hearing. One year later, Morimo-
to24 studied 33 TS patients with age ranging between 8 and 40 
years; 20 subjects showed high-frequency SNHL (60.1%) with 
a statistically significant correlation between hearing loss, age 
and body height (p<.001). Also, age-dependent hearing loss was 
more apparent in patients with monosomic 45,X kariotype than 
in those with the mosaic type. This was confirmed in a later study 
published in 2013 by Oliveira30 who reported a large prevalence 
of high frequency hearing loss in TS patients; those with a 45,X 
karyotype and isochromosomes with loss of the p-arm of the X 
chromosome had a greater risk of developing hearing loss than 
patients with mosaicism. Furthermore, the authors described 
a linear association between hearing loss and age in these pa-
tients. In 2008, Gawron25 studied 51 TS patients (median age: 
14.3 years), reporting recurrent acute otitis media in 19.6% of 
subjects, conductive hearing loss in 11.7%, mixed hearing loss 
in 5.9% and a moderate sensorineural hearing loss in 18.6%. 
The authors also reported altered ABR in 52% of the patients 
revealing a possible retrocochlear involvement. In the same year, 
a large study by Bergamaschi and colleagues26 was performed 
in 173 TS patients (median age: 12 years). Conductive hearing 
loss was found in 38.7% of patients: persistent secretory otitis 
media in 55.2%, chronic otitis media in 10.4%, pars flaccida re-
traction pocket in 19.4%, chronic otitis media with cholestea-
toma in 15% of the subjects. Sensorineural hearing loss occurred 
in 15.6% of the subjects, mostly bilateral (93%) for both high 
(42%) and mid (58%) frequencies. In a different paper, Parkin 
and Walker27 focused on 23 children with TS (median age: 10.4 
years), finding middle ear disease in 91% of subjects and SNHL 
in 9%. In 2009, Hederstierna28 conducted a longitudinal study 
of hearing decline in women with Turner syndrome, confirming 
that young and middle-aged women with TS have a progressive 
type of hearing impairment, deteriorating rapidly in adult age. 
The group of Verver of the Radboud University Nijmegen Medi-
cal Centre, Netherlands, published 2 studies on hearing function 
and TS. In the first, the authors studied a group of 60 children 
with TS and correlated their findings to karyotype, supporting 
the hypothesis that hearing can be affected by loss of the p-arm 
of the X-chromosome.29 In the second paper, published in 2014, 
the authors studied 65 TS patients finding a higher prevalence of 
Authors No. of patients Year of Publication
Leheupet al15 60 1988
Watkin et al16 24 1989
Sculerati et al9 22 1990
Hultcrantz et al17 44 1994
Sculerati et al18 24 1996
Hultcrantz et al19 40 1997
Benazzo et al6 62 1997
Stenberg et al7 56 1998
Barrenas et al20 115 1999
Barrenas et al21 119 2000
Gungo R et al12 38 2000
Serra et al4 21 2003
Hultcrantz10 325 2003
Beckam et al5 113 2004
Ostberg et al22 138 2004
Dhooge et al23 41 2005
Morimoto et al24 33 2006
Gawron et al25 51 2008
Bergamaschi et al26 153 2008
Parkin et al27 23 2008
Hederstierna et al28 69 2009
Verver et al29 60 2011
Oliveira et al30 52 2013
Ros et al31 31 2014
Verver et al32 65 2014
Bakhshaee et al33 24 2015








hearing disorders in patients with monosomy 45,X or isochro-
mosome 46,X,i(Xq), thus confirming the results of their previ-
ous study.32 In the same year, Ros compared 31 adult patients 
with TS to 15 women with other congenital hypogonadims and 
41 healthy age-matched women. Their findings confirmed that 
more than a half of TS females presented HL; SNHL was the 
most frequent pattern among middle-aged women with TS and 
old age, karyotype and recurrent otitis were predisposing factors 
to induce HL.31
CONCLUSION
In conclusion, literature confirms that hearing disorders, al-
though not the most relevant clinical problem in these patients, 
have a high incidence in individuals with TS. They can be both 
conductive due to morphological alterations common to other 
conditions with similar cranio-facial alterations, and sensorineu-
ral with a chronic worsening trend over time. Also, sensorineural 
hearing loss may not be clinically noticeable in most cases, espe-
cially at its onset and during the first decades of life. Therefore, 
it is always recommended investigating the hearing function in 
TS patients with subjective and objective techniques includ-
ing audiometry, otoacoustic emissions and auditory brainstem 
responses; both early hearing evaluation and monitoring over 
time are necessary. Because patients with TS can present with 
different manifestations affecting multiple systems, the otolar-
yngologist should be aware of TS and its association with hear-
ing disorders. Further studies are required to better understand 
the pathophysiologic basis of SNHL in patients with TS, while 
an increased clinical attention to conductive hearing loss in the 
recent years has contributed to a substantial decrease in chroni-
cization of hearing loss and its consequences.
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